Contrast Media - Global Strategic Business Report

Report
513 Pages
March 2024
Region: Global
Global Industry Analysts, Inc
ID: 4804626

The global market for Contrast Media is estimated at US$5 Billion in 2023 and is projected to reach US$6.2 Billion by 2030, growing at a CAGR of 2.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

Regional Analysis: Gain insights into the U.S. market, estimated at $2 Billion in 2023, and China, forecasted to grow at an impressive 3.9% CAGR to reach $409.3 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Contrast Media Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Contrast Media Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Contrast Media Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as GE Healthcare, Bayer AG, Ligand Pharmaceuticals, Inc., and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 45 Featured):

GE Healthcare
Bayer AG
Ligand Pharmaceuticals, Inc.
Bracco SpA
Trivitron Healthcare
Bracco Imaging SpA
Lantheus Medical Imaging, Inc.
Guerbet Group
Sanochemia Pharmazeutika AG
Beijing BeiLu Pharmaceutical Co., Ltd.
Fuji Pharma Co., Ltd.
Guerbet LLC
NanoHybrids
Bayer AG, Pharmaceuticals
FujiFilm VisualSonics, Inc.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
Prevalence of Chronic Diseases Among the Growing Global Population Pushes Up the Diagnostic Burden & Demand for Imaging
Rising Prevalence of Chronic Diseases Amplifies the Volume of Imaging Procedures, Driving Opportunities for Imaging Agents: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
The US$ 37 Billion Robustly Growing Medical Imaging Market Provides Lucrative Opportunities for Contrast Agents for Advanced Visualization: Global Medical Imaging Market (In US$ Billion) for the Years 2018, 2020 and 2022
Aging Population, a Demographic Catalyst Driving Demand for Imaging Services
Rapidly Aging Population & the Challenges Associated With Geriatric Imaging Spurs Demand for Contrast Imaging Agents: Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020 & 2025
Rise of Nuclear Medicine, the Cornerstone for the Growth for Radioactive Tracers
Improving Quality & Value of Nuclear Medicine Bodes Well for Radioactive Contrast Agents: Global Market for Nuclear Imaging (US$ Billion) for the Years 2018, 2020, 2022 and 2025 by Type
Short Supply of Technetium-99m Threatens to Impact Nuclear Imaging Services
Plagued by the Risk of Reactor Decommissioning & Unplanned Maintenance Shutdowns, Fragile Supply of Mo-99 Will Remain a Cause for Concern: Global Mo-99 Production Capacity (In Curies (Ci) Per Week) by Producer for the Years 2016 through 2022
Contrast Media - Global Key Competitors Percentage Market Share in 2023 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)

2. FOCUS ON SELECT PLAYERS

AMAG Pharmaceuticals, Inc. (USA)
Bayer Healthcare LLC (USA)
Bracco Imaging SpA (Italy)
GE Healthcare (USA)
Genovis AB (Sweden)
Guerbet Group (France)
J.B. Chemicals & Pharmaceuticals Ltd. (India)
Jodas Expoim (India)
Lantheus Medical Imaging, Inc. (USA)
Magnus Health (India)
Medtronic Plc. (Ireland)
nanoPET Pharma GmbH (Germany)
Sanochemia Pharmazeutika AG (Austria)
Spago Nanomedical AB (Sweden)
Taejoon Pharm Co., Ltd. (South Korea)
Unijules Life Sciences Ltd. (India)

3. MARKET TRENDS & DRIVERS

Migration to Value Based Care Throws the Focus on Quality & Value of Imaging & Its Ability to Improve Patient Care by Providing Better Quality Images
Growing Preference for Non-Ionizing Radiation-Based Radioimaging Drives Demand for Contrast Enhanced MRI
Commercially Available MRI Contrast Agents
Spurred by Safety & Efficiency Benefits, Growing MRI Procedures & Parallel Increase in MRI Machines to Benefit Demand for MRI Contrast Agents: Global MRI Equipment Market (In US$ Billion) for the Years 2018, 2020, 2022 and 2024
Evolving Clinical Applications of Contrast-Enhanced Ultrasound (CEUS) Drive Demand for Ultrasound Contrast Agents
Clinically Available Ultrasound Contrast Agents
Growing Use of CEUS in Emergency and Critical Care
Special Focus on Microbubble Contrast Agents for Ultrasound Imaging
Clinical Applications of Microbubbles
Oscillating Microbubbles: To Revolutionize Ultrasound
Growing Market for Ultrasound Equipment Pushes Up the Number of CEUS Procedures Performed: Global Market for Ultrasound Equipment (In US Billion) for the Years 2017, 2019, 2022 and 2024
Continued Value of CT Imaging in Cardiology Despite Risk of Radiation Exposure Drives Demand for Contrast-Enhanced CT
Contrast Agents Used in CT Imaging by Class: A Snapshot
CCTA Gaining Traction in Coronary Arteries Imaging
List of Iodine-Containing Contrast Agents for Coronary CT Angiography
Rise in Image Guided Surgeries Drives Demand for Contrast Agents
Emergence of Molecular-Targeted Fluorescent Tracers
Select Potential “always-on” Targeted Tracers for Fluorescence Image-Guided Surgery (FIGS)
The Use of Gold Nanoclusters as Contrast Agent for IGS of Head and Neck Tumors
Stringent Guidelines & Implementation of Best Practices for Safe Use of Contrast Agents to Encourage Patient Acceptance of Contrast Enhanced Imaging
Safety Issues with Iodinated Agents, Gadolinium BCA and Microbubbles
Symptoms of Reaction to Administration of Iodinated Contrast Media Agents
Innovations Remain Crucial to Growth
A Review of Advancements in Contrast Media Injector Technology
Development of New Contrast Agents
Key Challenges Confront the Market
Advances in Imaging Technology Reduce Contrast Media Use
Product Recalls and Side Effects of Contrast Media Challenge Growth
A Snapshot of Side Effects, Allergic and Adverse Reactions with Contrast Agents

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for X-ray/Computed Tomography (CT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 2: World Historic Review for X-ray/Computed Tomography (CT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 3: World 16-Year Perspective for X-ray/Computed Tomography (CT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 4: World Recent Past, Current & Future Analysis for Magnetic Resonance Imaging (MRI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 5: World Historic Review for Magnetic Resonance Imaging (MRI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 6: World 16-Year Perspective for Magnetic Resonance Imaging (MRI) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 8: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 9: World 16-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 10: World Recent Past, Current & Future Analysis for Barium-based Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 11: World Historic Review for Barium-based Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 12: World 16-Year Perspective for Barium-based Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 13: World Recent Past, Current & Future Analysis for Iodinated Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 14: World Historic Review for Iodinated Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 15: World 16-Year Perspective for Iodinated Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 16: World Recent Past, Current & Future Analysis for Gadolinium-based Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 17: World Historic Review for Gadolinium-based Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 18: World 16-Year Perspective for Gadolinium-based Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 19: World Recent Past, Current & Future Analysis for Microbubble Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 20: World Historic Review for Microbubble Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 21: World 16-Year Perspective for Microbubble Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 22: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 23: World Historic Review for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 24: World 16-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 25: World Recent Past, Current & Future Analysis for Interventional Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 26: World Historic Review for Interventional Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 27: World 16-Year Perspective for Interventional Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 28: World Recent Past, Current & Future Analysis for Interventional Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 29: World Historic Review for Interventional Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 30: World 16-Year Perspective for Interventional Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 31: World Contrast Media Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
Table 32: World Recent Past, Current & Future Analysis for Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 33: World Historic Review for Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 34: World 16-Year Perspective for Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

UNITED STATES

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)

CANADA

JAPAN

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)

CHINA

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)

EUROPE

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)

FRANCE

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)

GERMANY

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)

ITALY

UNITED KINGDOM

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)

SPAINRUSSIAREST OF EUROPE

ASIA-PACIFIC

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)

AUSTRALIA

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)

INDIA

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)

SOUTH KOREAREST OF ASIA-PACIFIC

LATIN AMERICA

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)

ARGENTINABRAZILMEXICOREST OF LATIN AMERICA

MIDDLE EAST

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)

IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST

AFRICA

Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

GE Healthcare
Bayer AG
Ligand Pharmaceuticals, Inc.
Bracco SpA
Trivitron Healthcare
Bracco Imaging SpA
Lantheus Medical Imaging, Inc.
Guerbet Group
Sanochemia Pharmazeutika AG
Beijing BeiLu Pharmaceutical Co., Ltd.
Fuji Pharma Co., Ltd.
Guerbet LLC
NanoHybrids
Bayer AG, Pharmaceuticals
FujiFilm VisualSonics, Inc.

Table Information

Report Attribute	Details
No. of Pages	513
Published	March 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 5 Billion
Forecasted Market Value ( USD ) by 2030	$ 6.2 Billion
Compound Annual Growth Rate	3.1%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5238EUR$5,450USD£4,429GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9953EUR$10,355USD£8,416GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15715EUR$16,350USD£13,288GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 45 Featured):

MarketGlass Platform

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Global Contrast Media Market by Type, Procedure, Route Of Administration, Application, End-user, Disease Indication - Forecast 2024-2030

U.S. Contrast Media Market Size, Share & Trends Analysis Report by Modality (Modality, Ultrasound, Magnetic Resonance Imaging (MRI), X-ray/Computed Tomography (CT Scan)), Type, Application, and Segment Forecasts, 2023-2030

Diagnostic Radiopharmaceuticals and Contrast Media - Global Strategic Business Report

Imaging Agents - Global Strategic Business Report

Global Contrast Media Market: Analysis By Type, By Indication, By Route of Administration, By Procedure, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029